Correlation Between Tarsus Pharmaceuticals and Biocardia

Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Biocardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Biocardia into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tarsus Pharmaceuticals and Biocardia, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Biocardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Biocardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Biocardia.

Diversification Opportunities for Tarsus Pharmaceuticals and Biocardia

-0.73

Correlation Coefficient

Tarsus Pharmaceuticals  Biocardia

Pay attention - limited upside

The 3 months correlation between Tarsus and Biocardia is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Biocardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biocardia and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Biocardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biocardia has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Biocardia go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Biocardia

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.38 times more return on investment than Biocardia. However, Tarsus Pharmaceuticals is 2.65 times less risky than Biocardia. It trades about 0.14 of its potential returns per unit of risk. Biocardia is currently generating about 0.01 per unit of risk. If you would invest  2,884  in Tarsus Pharmaceuticals on October 13, 2024 and sell it today you would earn a total of  2,385  from holding Tarsus Pharmaceuticals or generate 82.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Tarsus Pharmaceuticals  vs.  Biocardia

Tarsus Pharmaceuticals

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Biocardia

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biocardia has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Tarsus Pharmaceuticals and Biocardia

The main advantage of trading using opposite Tarsus Pharmaceuticals and Biocardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Biocardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocardia will offset losses from the drop in Biocardia's long position.

The idea behind Tarsus Pharmaceuticals and Biocardia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..